Index of reports
> Cases with Cytomegalovirus Infection (49)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include cytomegalovirus infection. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 49 Next >>
Possible Neoral side effects in female
Reported by a physician from United States on 2012-08-17
Patient: female
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Pneumonia Aspiration, Unresponsive To Stimuli, Wound, Herpes Simplex, Oedema Peripheral, Pulmonary Oedema, Apnoea, Cardiac Failure Congestive, Metabolic Acidosis, Malnutrition, Convulsion, Sepsis Syndrome, Fungal Infection, Ventricular Tachycardia, Depressed Level of Consciousness, Metabolic Encephalopathy, Confusional State, Brachiocephalic Vein Stenosis, Somnolence, Cytomegalovirus Gastritis, Multi-Organ Failure, Hearing Impaired, Acute Respiratory Failure, Sinusitis, Renal Failure Acute, Pneumonia Fungal, Dyspnoea, Hyponatraemia, Mental Impairment, Pneumonia Herpes Viral, Cytomegalovirus Infection, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Darbepoetin Alfa; Heparin; Atrovent; Metoprolol Tartrate; Lasix; Zyvox; Imodium; Acyclovir; Cefepime; Allopurinol; Bumex; Albuterol; Amlodipine; Micafungin; Gabapentin; Entecavir; Prednisolone; Pantoprazole; Insulin; Morphine; Prednisolone; Urea; Lovenox
Possible Neoral side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-13
Patient: 59 year old male
Reactions: Respiratory Disorder, Hallucination, Auditory, Motor Dysfunction, Acute Myeloid Leukaemia, Encephalopathy, Pyrexia, Parkinsonism, Cerebral Toxoplasmosis, Pneumonia Cytomegaloviral, Agnosia, Micturition Disorder, Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Memory Impairment, Altered State of Consciousness, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Methotrexate; Ganciclovir; Fludarabine Phosphate; Melphalan Hydrochloride
Possible Neoral side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-30
Patient: 64 year old male
Reactions: Interstitial Lung Disease, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Cyclophosphamide
Possible Neoral side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27
Patient: 64 year old male
Reactions: Interstitial Lung Disease, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Cyclophosphamide
Possible Neoral side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27
Patient: 64 year old male
Reactions: Interstitial Lung Disease, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Cyclophosphamide
Possible Neoral side effects in male
Reported by a physician from France on 2012-07-25
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Hydrocele Male Infected, Pyelonephritis Acute, Cytomegalovirus Infection, Renal Failure Acute, Infected Lymphocele
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mycophenolic Acid
Dosage: 350 mg, bid
Administration route: Oral
Start date: 2011-04-29
Prednisone
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2010-08-17
Mycophenolic Acid
Dosage: 720 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-12
End date: 2011-04-25
Neoral
Dosage: 75 mg, bid
Administration route: Oral
Start date: 2010-09-14
Neoral
Dosage: 150 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-13
End date: 2010-09-13
Other drugs received by patient: Prednisolone; Eupressyl; Atenolol; Hyperium
Possible Neoral side effects in male
Reported by a physician from Mexico on 2012-07-13
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: Jaundice, Gastrointestinal Haemorrhage, Pneumonia, Complications of Transplanted Kidney, Respiratory Failure, Cytomegalovirus Infection, Acute Respiratory Distress Syndrome, Gastritis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 25 mg, bid
Administration route: Oral
End date: 2012-06-13
Neoral
Dosage: 25 mg, bid
Administration route: Oral
Start date: 2012-06-18
Prednisone
Dosage: 15 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-05-16
End date: 2012-06-13
Neoral
Dosage: 50 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-05-02
Prednisone
Dosage: 15 mg, qd
Administration route: Oral
Other drugs received by patient: Acyclovir; Myfortic; Bactrim; Amlodipine; Myfortic; Nystatin; Metoprolol Tartrate; Losartan Potassium
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09
Patient: male, weighing 64.0 kg (140.8 pounds)
Reactions: Hepatitis B Antibody Positive, Epstein-Barr Virus Infection, Post Transplant Lymphoproliferative Disorder, Primary Mediastinal Large B-Cell Lymphoma, Cytomegalovirus Test Positive, Blood Uric Acid Increased, Cytomegalovirus Infection, Pyrexia, Hepatic Neoplasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simulect
Dosage: 20 mg, once/single
Start date: 2007-05-20
End date: 2007-05-20
Cellcept
Dosage: 1500 mg/day
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-17
Neoral
Dosage: 500 mg/day
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-13
End date: 2007-05-23
Simulect
Dosage: 20 mg, once/single
Indication: Renal Transplant
Start date: 2007-05-16
End date: 2007-05-16
Other drugs received by patient: Sandimmune; Cinalong; Diovan; Solu-Medrol; Zyloric ^fresenius^; Prednisolone; Prednisolone; Allopurinol
Possible Neoral side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-23
Patient: 52 year old female
Reactions: White Blood Cell Count Decreased, Hepatic Function Abnormal, Drug Ineffective, Hepatic Failure, Pancytopenia, Pyrexia, Oropharyngeal Pain, Herpes Zoster, Epstein-Barr Virus Infection, Fatigue, Pharyngeal Oedema, Hepatic Encephalopathy, Herpes Simplex, Peliosis Hepatis, Acute Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Hepatitis B
Adverse event resulted in: death
Drug(s) suspected as cause:
ATG-Fresenius
Dosage: unk ukn, unk
Thymoglobulin
Dosage: 2.5 mg/kg, per day
Metenolone Acetate
Dosage: unk ukn, unk
Immune Globulin (Human)
Dosage: unk ukn, unk
Neoral
Dosage: 130 mg, daily
Administration route: Oral
Start date: 2009-01-14
End date: 2009-05-02
Neoral
Dosage: 3 mg/kg, per day
Indication: Bone Marrow Transplant
Thymoglobulin
Dosage: 110 mg daily
Start date: 2009-01-09
End date: 2009-01-12
Other drugs received by patient: Methotrexate; Acyclovir; Platelets; Levofloxacin; Acyclovir; Moxifloxacin; RED Blood Cells; Methotrexate; Fludarabine Phosphate; Cytoxan; Filgrastim; Fluconazole; Acyclovir; Pentamidine Isethionate
Possible Neoral side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-22
Patient: 52 year old female
Reactions: White Blood Cell Count Decreased, Hepatic Function Abnormal, Drug Ineffective, Hepatic Failure, Pancytopenia, Oropharyngeal Pain, Pyrexia, Herpes Zoster, Epstein-Barr Virus Infection, Pharyngeal Oedema, Fatigue, Hepatic Encephalopathy, Herpes Simplex, Peliosis Hepatis, Acute Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Hepatitis B
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Dosage: 130 mg, daily
Administration route: Oral
Start date: 2009-01-14
End date: 2009-05-02
Thymoglobulin
Dosage: 2.5 mg/kg, per day
Immune Globulin (Human)
Dosage: unk ukn, unk
ATG-Fresenius
Dosage: unk ukn, unk
Thymoglobulin
Dosage: 110 mg daily
Start date: 2009-01-09
End date: 2009-01-12
Neoral
Dosage: 3 mg/kg, per day
Indication: Bone Marrow Transplant
Metenolone Acetate
Dosage: unk ukn, unk
Other drugs received by patient: Cyclophosphamide; Pentamidine Isethionate; Acyclovir; Moxifloxacin; RED Blood Cells; Fludarabine Phosphate; Methotrexate; Acyclovir; Methotrexate; Levofloxacin; Fluconazole; Acyclovir; Filgrastim; Platelets
Possible Neoral side effects in 37 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-18
Patient: 37 year old female
Reactions: Subdural Haematoma, Hepatic Function Abnormal, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Acute Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Chronic Graft Versus Host Disease
Drug(s) suspected as cause:
Cytarabine
Dosage: unk ukn, unk
Start date: 2009-05-16
End date: 2009-05-22
Gleevec
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2009-06-30
Methotrexate
Dosage: 15 mg/m2, unk
Methotrexate
Dosage: 10 mg/m2, unk
Neoral
Dosage: 80 mg, unk
Administration route: Oral
Neoral
Dosage: 120 mg, unk
Administration route: Oral
Start date: 2010-01-01
Idarubicin Hydrochloride
Dosage: unk ukn, unk
Start date: 2009-05-16
End date: 2009-05-18
Neoral
Dosage: 60 mg, unk
Administration route: Oral
Gleevec
Dosage: 600 mg, daily
Administration route: Oral
Indication: Chronic Myeloid Leukaemia Transformation
Start date: 2009-05-23
End date: 2009-06-16
Methotrexate
Dosage: 10 mg/m2, unk
Other drugs received by patient: Prednisolone
Possible Neoral side effects in 37 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-15
Patient: 37 year old female
Reactions: Subdural Haematoma, Hepatic Function Abnormal, Acute Graft Versus Host Disease in Skin, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytomegalovirus Infection, Chronic Graft Versus Host Disease
Drug(s) suspected as cause:
Gleevec
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2009-06-30
Gleevec
Dosage: 600 mg, daily
Administration route: Oral
Indication: Chronic Myeloid Leukaemia Transformation
Start date: 2009-05-23
End date: 2009-06-16
Neoral
Dosage: 80 mg, unk
Administration route: Oral
Idarubicin Hydrochloride
Dosage: unk ukn, unk
Start date: 2009-05-16
End date: 2009-05-18
Methotrexate
Dosage: 15 mg/m2, unk
Neoral
Dosage: 60 mg, unk
Administration route: Oral
Methotrexate
Dosage: 10 mg/m2, unk
Methotrexate
Dosage: 10 mg/m2, unk
Neoral
Dosage: 120 mg, unk
Administration route: Oral
Start date: 2010-01-01
Cytarabine
Dosage: unk ukn, unk
Start date: 2009-05-16
End date: 2009-05-22
Other drugs received by patient: Prednisolone
Possible Neoral side effects in
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-14
Patient:
Reactions: Respiratory Failure, Cytomegalovirus Infection, Meningitis Viral
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Basiliximab; Corticosteroids
Possible Neoral side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-09
Patient: 50 year old male
Reactions: Guillain-Barre Syndrome, Dyspnoea, Dysphagia, Acute Graft Versus Host Disease, Muscular Weakness, Paralysis, Pyrexia, Nerve Conduction Studies Abnormal, Neuropathy Peripheral, Dysphonia, Diarrhoea, Sensory Disturbance, Cytomegalovirus Infection, Areflexia, Erythema Multiforme
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 200 mg, daily
Administration route: Oral
Indication: Allogenic Bone Marrow Transplantation Therapy
Sandimmune
Dosage: 4 mg/kg, daily
Indication: Allogenic Bone Marrow Transplantation Therapy
Other drugs received by patient: Prednisolone
Possible Neoral side effects in 40 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-30
Patient: 40 year old female
Reactions: Abdominal Pain, Blood Urea Increased, Blood Potassium Increased, Pancytopenia, Idiopathic Thrombocytopenic Purpura, Renal Failure, Immunoglobulins Decreased, Systemic Lupus Erythematosus, Thrombocytosis, Cytomegalovirus Infection, Platelet Count Decreased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Valganciclovir
Dosage: 240 mg, unk
Administration route: Oral
Indication: Cytomegalovirus Infection
Start date: 2010-02-01
Adrenal Cortical Extract
Dosage: 15 mg, unk
Administration route: Oral
Indication: Systemic Lupus Erythematosus
Start date: 2009-10-01
Neoral
Dosage: 125 mg daily
Administration route: Oral
Indication: Systemic Lupus Erythematosus
Start date: 2009-10-01
End date: 2010-02-01
Other drugs received by patient: Immune Globulin (Human); Immune Globulin (Human); Steroids NOS
Possible Neoral side effects in male
Reported by a physician from France on 2012-04-20
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Bronchial Obstruction, Klebsiella Infection, Thrombocytopenia, Post Procedural Haemorrhage, Escherichia Sepsis, Renal Vessel Disorder, Complications of Transplanted Kidney, Wound Dehiscence, Anaemia, Malnutrition, Anastomotic Haemorrhage, Wound Complication, Renal Impairment, Diarrhoea, Cytomegalovirus Infection, Renal Tubular Necrosis, Pneumonia Escherichia, Asthenia, Leukopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2011-02-10
Mycophenolate Mofetil (Cellcept)
Dosage: 1 g, per day
Administration route: Oral
Start date: 2011-03-01
End date: 2011-03-08
Bactrim
Dosage: 400 mg, per day
Administration route: Oral
Start date: 2011-01-24
End date: 2011-02-01
RAD 666 / RAD 001a
Dosage: 3 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-02-02
End date: 2011-02-09
Neoral
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2011-02-27
End date: 2011-03-16
Neoral
Dosage: unk
Mycophenolate Mofetil (Cellcept)
Dosage: 2 g, per day
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-15
End date: 2011-02-09
Neoral
Dosage: 400 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-17
End date: 2011-02-01
Prednisone TAB
Dosage: 40 mg, per day
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-16
Zantac
Dosage: 150 mg, per day
Administration route: Oral
Start date: 2011-02-02
Valganciclovir
Dosage: 250 mg, 9qd
Administration route: Oral
Start date: 2011-01-29
End date: 2011-02-01
Nexium
Dosage: 40 mg, per day
Administration route: Oral
Start date: 2011-01-16
End date: 2011-02-01
Other drugs received by patient: Solu-Medrol; Lasix; Adancor; Esomeprazole Magnesium; Calcidia; Pantoprazole; Aspirin; Sodium Bicarbonate; Amlodipine Besylate; Econazole Nitrate; Amoxicillin; Imodium; Simulect; Eprex; Insulatard NPH Human; Potassium Chloride; Nitroderm; Mirtazapine; Aluminum Hydroxide and Magnesium Trisilicate; Alfuzosin HCL; Cotrim
Possible Neoral side effects in female
Reported by a physician from Japan on 2012-04-19
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Pyrexia, Rash, Kidney Transplant Rejection, Urine Abnormality, Hypokinesia, Renal Impairment, Cytomegalovirus Infection, Pneumonia Staphylococcal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simulect
Dosage: 20 mg, once/single
Indication: Renal Transplant
Start date: 2010-01-20
End date: 2010-01-20
Rituxan
Dosage: 200 mg, unk
Start date: 2010-05-25
Mycophenolate Mofetil (Cellcept)
Dosage: 1800 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-01-06
End date: 2010-01-19
Mycophenolate Mofetil (Cellcept)
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2010-01-24
Mycophenolate Mofetil (Cellcept)
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2010-01-21
Neoral
Dosage: 300 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-01-17
End date: 2010-01-19
Neoral
Dosage: 200 mg
Administration route: Oral
Start date: 2010-03-02
End date: 2010-10-03
Neoral
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2010-10-04
Prednisolone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-01-24
End date: 2010-01-25
Prednisolone
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2010-01-29
End date: 2010-01-30
Simulect
Dosage: 20 mg, once/single
Start date: 2010-01-24
End date: 2010-01-24
Neoral
Dosage: 300 mg, qd
Start date: 2010-01-23
End date: 2010-02-06
Neoral
Dosage: 150 mg, unk
Start date: 2011-01-24
End date: 2011-10-12
Neoral
Dosage: 250 mg, qd
Administration route: Oral
Start date: 2010-02-07
End date: 2010-03-01
Neoral
Dosage: 100 mg, unk
Start date: 2011-10-13
Sandimmune
Dosage: 100 mg, unk
Indication: Renal Transplant
Start date: 2010-01-20
End date: 2010-01-22
Prednisolone
Dosage: 30 mg, unk
Administration route: Oral
Start date: 2010-01-26
End date: 2010-01-28
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2010-01-31
Rituxan
Dosage: 200 mg, unk
Indication: Kidney Transplant Rejection
Start date: 2010-01-13
End date: 2010-01-13
Other drugs received by patient: Spanidin; Solu-Medrol; Adalat CC; Adalat; Solu-Medrol
Possible Neoral side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-20
Patient: 67 year old female
Reactions: Atelectasis, Lymphadenopathy, Corneal Perforation, Conjunctivitis, Glossitis, Forced Expiratory Volume Decreased, Ulcerative Keratitis, Obliterative Bronchiolitis, Erythema, Alternaria Infection, Skin Ulcer, Lymphocytic Lymphoma, Bronchial Wall Thickening, Bronchospasm, Blister, Stomatitis, Dyspnoea, Pneumonia, Subcutaneous Abscess, Pain of Skin, Rash, Respiratory Distress, Renal Impairment, Respiratory Failure, Fungal Skin Infection, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone
Possible Neoral side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-15
Patient: male
Reactions: Cardio-Respiratory Arrest, Pneumonia, Diarrhoea, Sepsis, Cytomegalovirus Infection, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 75 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-06-05
End date: 2011-11-07
Mycophenolate Mofetil (Cellcept)
Dosage: unk
Administration route: Oral
Indication: Renal Transplant
End date: 2011-10-24
Other drugs received by patient: Folvite; Arkamin; Sodium Bicarbonate; Dilzem; Deflazacort; Pantocid (Pantoprazole Sodium); Azathioprine; Calcium Gluconate; Atenolol; Pantoprazole; Racecadotril
Possible Neoral side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-15
Patient: male
Reactions: Cardio-Respiratory Arrest, Pneumonia, Diarrhoea, Sepsis, Cytomegalovirus Infection, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 75 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-06-05
End date: 2011-11-07
Mycophenolate Mofetil (Cellcept)
Dosage: unk
Administration route: Oral
Indication: Renal Transplant
End date: 2011-10-24
Other drugs received by patient: Folvite; Atenolol; Racecadotril; Sodium Bicarbonate; Dilzem; Calcium Gluconate; Deflazacort; Arkamin; Azathioprine; Pantoprazole; Pantocid (Pantoprazole Sodium)
Possible Neoral side effects in 60 year old male
Reported by a physician from France on 2012-03-12
Patient: 60 year old male
Reactions: BK Virus Infection, Cytomegalovirus Infection, Pseudomembranous Colitis, Epstein-Barr Viraemia, Lymphoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Myfortic
Administration route: Oral
Indication: Immunosuppression
Start date: 2011-03-01
End date: 2011-06-01
Mabcampath
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-29
End date: 2011-08-01
Certican
Neoral
Administration route: Oral
Indication: Immunosuppression
Start date: 2011-03-01
End date: 2011-06-01
Mabthera
Indication: Acute Myeloid Leukaemia
Start date: 2011-07-01
Certican
Dosage: dose decreased
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-01
End date: 2011-08-01
Mabcampath
Start date: 2011-08-11
Prograf
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Neoral side effects in male
Reported by a physician from Belgium on 2012-03-08
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Pneumonia, Drug Level Increased, Diarrhoea, Dehydration, Duodenal Ulcer, Cytomegalovirus Infection, Neurological Symptom, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Digoxin
Dosage: unspecified
Medrol
Administration route: Oral
Start date: 1995-09-17
Neoral
Administration route: Oral
Start date: 1995-08-08
Possible Neoral side effects in male
Reported by a physician from United States on 2012-03-08
Patient: male, weighing 83.0 kg (182.6 pounds)
Reactions: Abdominal Discomfort, Postoperative Wound Complication, Ileus, Cytomegalovirus Infection, Pyrexia, Lethargy, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Ganciclovir; Prednisone TAB; Azathioprine
Possible Neoral side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07
Patient: 60 year old male
Reactions: Graft Versus Host Disease, Tuberculosis, Pseudomembranous Colitis, Cytomegalovirus Infection, Epstein-Barr Viraemia, Pancytopenia, Lymphoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neoral
Dosage: 100 mg, qd
Indication: Immunosuppression
Myfortic
Indication: Immunosuppression
Certican
Dosage: 0.25 mg, bid
Administration route: Oral
Mabthera
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-07-01
End date: 2011-07-01
Mabthera
Dosage: unk
Neoral
Dosage: 160 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-03-01
End date: 2011-06-01
Prograf
Dosage: unk
Indication: Graft Versus Host Disease in Skin
Campath
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-07-29
End date: 2011-08-01
Campath
Dosage: unk
Start date: 2011-08-11
Certican
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-06-01
End date: 2011-08-01
Myfortic
Dosage: 750 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-01
End date: 2011-06-01
Possible Neoral side effects in 60 year old male
Reported by a physician from France on 2012-03-06
Patient: 60 year old male
Reactions: Hepatic Mass, B-Cell Lymphoma, Mediastinal Mass, Pancytopenia, Pyrexia, Epstein-Barr Virus Infection, Diarrhoea, Graft Versus Host Disease in Skin, Proctitis Herpes, BK Virus Infection, Graft Versus Host Disease in Intestine, Cytomegalovirus Infection, Pseudomembranous Colitis, Clostridial Infection, Decreased Appetite
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Myfortic
Dosage: 750 mg, tid
Administration route: Oral
Start date: 2011-03-01
End date: 2011-06-01
Certican
Dosage: 0.5 mg, bid
Administration route: Oral
Start date: 2011-06-01
Valganciclovir
Indication: Cytomegalovirus Infection
End date: 2011-09-01
Mabthera
Start date: 2011-07-01
Neoral
Dosage: 100 mg, unk
Administration route: Oral
End date: 2011-06-01
Certican
Dosage: 0.25 mg, bid
Administration route: Oral
Start date: 2011-07-29
End date: 2011-08-01
Mabcampath
Start date: 2011-07-29
Mabcampath
Start date: 2011-08-11
Prograf
Indication: Graft Versus Host Disease in Skin
Neoral
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2011-03-01
Other drugs received by patient: Granocyte; Vistide
Possible Neoral side effects in 12 year old female
Reported by a consumer/non-health professional from United States on 2012-02-29
Patient: 12 year old female
Reactions: Cytomegalovirus Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Tacrolimus; Azathioprine; Mycophenolate Mofetil
Possible Neoral side effects in male
Reported by a physician from France on 2012-02-28
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Impaired Healing, Hypercreatininaemia, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
Dosage: 500 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-09-19
End date: 2011-11-19
RAD 666 / RAD 001a
Dosage: 1.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-09-24
End date: 2011-10-03
Neoral
Dosage: 750 + 150mg
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-07
Mycophenolate Mofetil (Cellcept)
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2011-11-26
Prednisone TAB
Dosage: 10 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-09-25
Possible Neoral side effects in 43 year old male
Reported by a physician from Japan on 2012-02-27
Patient: 43 year old male
Reactions: Cellulitis, Arthralgia, Food Poisoning, Dehydration, Cytomegalovirus Infection, Pyrexia, Arthritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 250 mg, unk
Administration route: Oral
Start date: 2009-10-23
Mycophenolate Mofetil (Cellcept)
Dosage: 1000 mg, unk
Administration route: Oral
Start date: 2009-09-30
Prednisolone
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2009-09-12
End date: 2009-09-18
Neoral
Dosage: 500 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-08-23
End date: 2009-09-01
Neoral
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2010-10-05
Sandimmune
Dosage: unk ukn, unk
Indication: Renal Transplant
Start date: 2009-09-02
Prednisolone
Dosage: 40 mg, unk
Start date: 2009-09-06
End date: 2009-09-08
Prednisolone
Dosage: 30 mg, unk
Administration route: Oral
Start date: 2009-09-09
End date: 2009-09-11
Prednisolone
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2009-10-02
Neoral
Dosage: 350 mg, unk
Administration route: Oral
Start date: 2009-10-06
Prednisolone
Dosage: 50 mg, unk
Administration route: Oral
Start date: 2009-09-02
End date: 2009-09-05
Neoral
Dosage: 500 mg, unk
Administration route: Oral
Start date: 2009-09-03
Neoral
Dosage: 300 mg, unk
Administration route: Oral
Start date: 2009-10-13
Mycophenolate Mofetil (Cellcept)
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-08-05
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2009-09-19
End date: 2009-10-01
Neoral
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2009-09-11
Mycophenolate Mofetil (Cellcept)
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2009-09-03
End date: 2009-09-29
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-08-28
End date: 2009-09-01
Other drugs received by patient: Valganciclovir; Tamiflu; Simulect; Simulect; Methylprednisolone Sodium Succinate; Rituxan
Possible Neoral side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24
Patient: 69 year old female
Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Lactic Acidosis, Pyrexia, Liver Disorder, Epstein-Barr Virus Infection, Multi-Organ Failure, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
Dosage: 3.5 mg/kg for five days
Indication: Aplastic Anaemia
Start date: 2010-09-15
Foscavir
Dosage: unk ukn, unk
Neoral
Dosage: 200 mg, qd
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2010-05-01
Other drugs received by patient: Neupogen; Blood and Related Products; Primobolan-Depot INJ
Possible Neoral side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21
Patient: 69 year old female
Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Pyrexia, Lactic Acidosis, Liver Disorder, Multi-Organ Failure, Epstein-Barr Virus Infection, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
Dosage: 3.5 mg/kg for five days
Indication: Aplastic Anaemia
Start date: 2010-09-15
Foscavir
Dosage: unk ukn, unk
Neoral
Dosage: 200 mg, qd
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2010-05-01
Other drugs received by patient: Primobolan-Depot INJ; Blood and Related Products; Neupogen
Page 1 Next >>
|